245 related articles for article (PubMed ID: 2005887)
1. Loss of the amino-terminal helix-loop-helix domain of the vav proto-oncogene activates its transforming potential.
Katzav S; Cleveland JL; Heslop HE; Pulido D
Mol Cell Biol; 1991 Apr; 11(4):1912-20. PubMed ID: 2005887
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of activation of the vav protooncogene.
Coppola J; Bryant S; Koda T; Conway D; Barbacid M
Cell Growth Differ; 1991 Feb; 2(2):95-105. PubMed ID: 2069873
[TBL] [Abstract][Full Text] [Related]
3. Single point mutations in the SH2 domain impair the transforming potential of vav and fail to activate proto-vav.
Katzav S
Oncogene; 1993 Jul; 8(7):1757-63. PubMed ID: 8510922
[TBL] [Abstract][Full Text] [Related]
4. vav, a novel human oncogene derived from a locus ubiquitously expressed in hematopoietic cells.
Katzav S; Martin-Zanca D; Barbacid M
EMBO J; 1989 Aug; 8(8):2283-90. PubMed ID: 2477241
[TBL] [Abstract][Full Text] [Related]
5. Involvement of NH(2)-terminal sequences in the negative regulation of Vav signaling and transforming activity.
Abe K; Whitehead IP; O'Bryan JP; Der CJ
J Biol Chem; 1999 Oct; 274(43):30410-8. PubMed ID: 10521418
[TBL] [Abstract][Full Text] [Related]
6. Molecular cloning and characterization of the human dbl proto-oncogene: evidence that its overexpression is sufficient to transform NIH/3T3 cells.
Ron D; Tronick SR; Aaronson SA; Eva A
EMBO J; 1988 Aug; 7(8):2465-73. PubMed ID: 3056717
[TBL] [Abstract][Full Text] [Related]
7. Major transcript variants of VAV3, a new member of the VAV family of guanine nucleotide exchange factors.
Trenkle T; McClelland M; Adlkofer K; Welsh J
Gene; 2000 Mar; 245(1):139-49. PubMed ID: 10713454
[TBL] [Abstract][Full Text] [Related]
8. Structure and function of vav.
Romero F; Fischer S
Cell Signal; 1996 Dec; 8(8):545-53. PubMed ID: 9115846
[TBL] [Abstract][Full Text] [Related]
9. Activation of the Lbc Rho exchange factor proto-oncogene by truncation of an extended C terminus that regulates transformation and targeting.
Sterpetti P; Hack AA; Bashar MP; Park B; Cheng SD; Knoll JH; Urano T; Feig LA; Toksoz D
Mol Cell Biol; 1999 Feb; 19(2):1334-45. PubMed ID: 9891067
[TBL] [Abstract][Full Text] [Related]
10. Mutagenic analysis of Vav reveals that an intact SH3 domain is required for transformation.
Groysman M; Nagano M; Shaanan B; Katzav S
Oncogene; 1998 Sep; 17(12):1597-606. PubMed ID: 9794237
[TBL] [Abstract][Full Text] [Related]
11. Genomic organization and regulation of the vav proto-oncogene.
Denkinger DJ; Borges CR; Butler CL; Cushman AM; Kawahara RS
Biochim Biophys Acta; 2000 Apr; 1491(1-3):253-62. PubMed ID: 10760587
[TBL] [Abstract][Full Text] [Related]
12. The sequences of the human and mouse c-cbl proto-oncogenes show v-cbl was generated by a large truncation encompassing a proline-rich domain and a leucine zipper-like motif.
Blake TJ; Shapiro M; Morse HC; Langdon WY
Oncogene; 1991 Apr; 6(4):653-7. PubMed ID: 2030914
[TBL] [Abstract][Full Text] [Related]
13. Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains.
Takahashi M; Buma Y; Iwamoto T; Inaguma Y; Ikeda H; Hiai H
Oncogene; 1988 Nov; 3(5):571-8. PubMed ID: 3078962
[TBL] [Abstract][Full Text] [Related]
14. Zinc finger domains and phorbol ester pharmacophore. Analysis of binding to mutated form of protein kinase C zeta and the vav and c-raf proto-oncogene products.
Kazanietz MG; Bustelo XR; Barbacid M; Kolch W; Mischak H; Wong G; Pettit GR; Bruns JD; Blumberg PM
J Biol Chem; 1994 Apr; 269(15):11590-4. PubMed ID: 8157692
[TBL] [Abstract][Full Text] [Related]
15. The hematopoietically expressed vav proto-oncogene shares homology with the dbl GDP-GTP exchange factor, the bcr gene and a yeast gene (CDC24) involved in cytoskeletal organization.
Adams JM; Houston H; Allen J; Lints T; Harvey R
Oncogene; 1992 Apr; 7(4):611-8. PubMed ID: 1565462
[TBL] [Abstract][Full Text] [Related]
16. Rac-1 dependent stimulation of the JNK/SAPK signaling pathway by Vav.
Crespo P; Bustelo XR; Aaronson DS; Coso OA; Lopez-Barahona M; Barbacid M; Gutkind JS
Oncogene; 1996 Aug; 13(3):455-60. PubMed ID: 8760286
[TBL] [Abstract][Full Text] [Related]
17. Association of Bcr-Abl with the proto-oncogene Vav is implicated in activation of the Rac-1 pathway.
Bassermann F; Jahn T; Miething C; Seipel P; Bai RY; Coutinho S; Tybulewicz VL; Peschel C; Duyster J
J Biol Chem; 2002 Apr; 277(14):12437-45. PubMed ID: 11790798
[TBL] [Abstract][Full Text] [Related]
18. N-terminally truncated Vav induces the formation of depolymerization-resistant actin filaments in NIH 3T3 cells.
Kranewitter WJ; Gimona M
FEBS Lett; 1999 Jul; 455(1-2):123-9. PubMed ID: 10428485
[TBL] [Abstract][Full Text] [Related]
19. Vav and Ras induce fibroblast transformation by overlapping signaling pathways which require c-Myc function.
Katzav S; Packham G; Sutherland M; Aroca P; Santos E; Cleveland JL
Oncogene; 1995 Sep; 11(6):1079-88. PubMed ID: 7566967
[TBL] [Abstract][Full Text] [Related]
20. Vav: Captain Hook for signal transduction?
Katzav S
Crit Rev Oncog; 1995; 6(2):87-97. PubMed ID: 8792085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
